The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2023
Filed:
Dec. 04, 2020
Applicant:
Theravance Biopharma R&d Ip, Llc, South San Francisco, CA (US);
Inventors:
Svitlana Kulyk, Redwood City, CA (US);
Christina Owens, Oakland, CA (US);
Steven D. E. Sullivan, San Francisco, CA (US);
Jennifer Kozak, Pacifica, CA (US);
Adam D. Hughes, Half Moon Bay, CA (US);
Assignee:
Theravance Biopharma R&D IP, LLC, South San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4375 (2006.01); A61K 9/00 (2006.01); A61K 31/439 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 31/4985 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); C07D 401/14 (2006.01); C07D 471/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4375 (2013.01); A61K 9/0073 (2013.01); A61K 31/439 (2013.01); A61K 31/4545 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01); C07D 401/14 (2013.01); C07D 471/04 (2013.01); C07D 519/00 (2013.01);
Abstract
The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.